シャロン・ペレス医師は消化管腫瘍を専門とし、ロンドンの名高いロイヤル・マーズデン癌センターで研鑽を積みました。
メリムスキー教授は膵臓癌を専門とし、スーラスキー医療センターにて数十年にわたる腫瘍学の経験を有しています。
Prof. Nadir Arber is a top gastroenterologist from Israel with over 30 years of experience in the field. He is specialized in the prevention, early diagnostics, and treatment of GI cancers, with education from Hebrew University, Tel Aviv University, and NewYork-Presbyterian Center. He has written over 300 papers on his research and is a member of numerous organizations in the field.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
ソウラスキー・メディカルセンターの腫瘍科部門全体を統括し、イスラエル国家がん政策評議会の顧問を務める。国内トップクラスの病院における上級職での豊富な経験を有する。
Dr. Auala Hubert is a board-certified medical oncologist and radiotherapist with 33 years of clinical experience. She works at Hadassah Medical Center and speaks both English and Hebrew. Dr. Hubert leads the Gastrointestinal Cancer Center. She is also a senior physician in the Oncology Department.
She earned her M.D. from Hadassah University Hospital. She holds board certifications in oncology and radiotherapy. Dr. Hubert has passed USMLE Parts I and II. She is a member of the Israel Society of Clinical Oncology, Israel Medical Society, and Israel Cancer Association. Dr. Hubert also serves on several medical and social service committees, where she helps advance cancer care.
Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.
He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.
Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.
Department:
Gastrointestinal Cancer Department
Specialties:
Internal Medicine, Medical Oncology, Cancer Epidemiology
Prof. Ben Boursi is a leading specialist in Internal Medicine, Medical Oncology, and Radiotherapy at Sheba Medical Center. He earned his medical degree with distinction (cum laude) from the School of Medicine at Tel Aviv University.
He completed his residency in Internal Medicine at Sourasky Medical Center in Tel Aviv, followed by advanced subspecialty training in Gastrointestinal Oncology and Cancer Epidemiology at the University of Pennsylvania, USA.
Academic and Research Appointments
Prof. Boursi holds an academic position within the Department of Epidemiology and Preventive Medicine at the School of Medicine, Tel Aviv University. In addition, he serves as an Associate Scholar at the Perelman School of Medicine, University of Pennsylvania.
Research and Scientific Contributions
Prof. Boursi’s research is centered on developing innovative therapeutic approaches in oncology, with a particular focus on the role of the microbiome in cancer development and treatment response.
He is internationally recognized as a leader in microbial modulation in cancer therapy and founded the ECOG-ACRIN Microbiome Working Group. His work has been published in leading scientific journals, including Science, and presented at major global oncology conferences, as well as featured in ASCO educational platforms and podcasts.
Alongside his research, Prof. Boursi is actively involved in academic teaching, delivering lectures on host–microbiome interactions at Tel Aviv University and Bar-Ilan University.
His research also extends to cancer prevention and early detection. He has developed predictive models for early diagnosis of colorectal and pancreatic cancers, which are currently undergoing clinical evaluation.
Clinical Expertise
Gastrointestinal oncology
Current Position
Physician, Gastrointestinal Cancer Department
Education and Training
B.Med.Sc (Summa cum laude), School of Medicine, Tel Aviv University
MD (Magna cum laude), School of Medicine, Tel Aviv University
Clinical and Research Fellowship in Gastrointestinal Oncology and Cancer Epidemiology, Perelman School of Medicine, University of Pennsylvania
Elective Training in Medical Oncology, MD Anderson Cancer Center
Elective Training in Medical Oncology, Mayo Clinic
Advanced Research Training, Weizmann Institute of Science
Board Certifications
Internal Medicine
Medical Oncology
Professional Memberships
Israeli Association of Clinical Oncology and Radiotherapy (ISCORT)
American Society for Cancer Research
Selected Publications
Immune-related adverse events as predictors of durable response to BRAF inhibitors in metastatic melanoma with BRAF V600 mutation
Ben-Betzalel G, Baruch EN, Boursi B, et al.
Re-evaluating the IDEA classification: Novel predictive and prognostic markers in stage III colon cancer
Margalit O, Mamtani R, Yang YX, Boursi B, et al.
Prognostic significance of carcinoembryonic antigen (CEA) levels in stage I–II colon cancer
Margalit O, Mamtani R, Yang YX, Boursi B, et al
Professional Profile
Dr. Almog Ben-Yaacov is a highly experienced surgeon specializing in general and oncological surgery. He graduated with honors from Semmelweis University Medical School in 2006. Following graduation, he completed two years of training in cardiac surgery, after which he continued with six additional years of advanced training in general surgery.
He currently serves as a senior surgeon at Sheba Medical Center. His clinical focus includes cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC), as well as the management of gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, Dr. Ben-Yaacov has performed over 200 HIPEC procedures.
Advanced Training
Dr. Ben-Yaacov has completed multiple specialized international training programs, including:
ESSO-certified HIPEC surgery course in Hamburg, Germany
Microwave liver ablation training in Reims, France
NanoKnife (irreversible electroporation) training at King’s College, London
In 2019, he further expanded his expertise through advanced surgical oncology training at Memorial Sloan Kettering Cancer Center, New York, USA.
Clinical Expertise & Procedures
Cytoreductive surgery with HIPEC
Resection of abdominal wall metastases
Minimally invasive and laparoscopic surgery
General and gastrointestinal surgery
Colorectal surgery
Laparoscopic cholecystectomy
Abdominal surgery
Surgical oncology
NanoKnife (irreversible electroporation)
Laparotomy
Current Position
Attending Surgeon, Department of General and Oncological Surgery (Surgery C)
Education & Surgical Training
MD (with honors), Semmelweis University Medical School, Hungary
Cardiothoracic Surgery Training, Sheba Medical Center
General Surgery Training, Montefiore Medical Center (Einstein Campus), New York, USA
General Surgery Training, Rabin Medical Center (Beilinson Campus), Israel
Board Certifications
General Surgery
Surgical Oncology
Selected Publications
Correlation Between Intraoperative and Pathological Findings in Patients Undergoing CRS and HIPEC
Berger Y, Jacoby H, Kaufmann MI, Ben-Yaacov A, et al.
Laparoscopic vs Open Hartmann’s Reversal: A Decade-Long Multicenter Retrospective Study
Horesh N, Lessing Y, Rudnicki Y, Ben-Yaacov A, et al.
Readmission Rates and Risk Factors Following CRS and HIPEC for Peritoneal Surface Malignancies
Dreznik Y, Hoffman A, Hamburger T, Ben-Yaacov A, et al.
Department:
The Endocrinology and Diabetes Research Center
The Endocrine Institute & Endocrine Oncology Bioinformatics Lab
Specialties:
Neuroendocrine Tumors
Professional Profile
Prof. Amit Tirosh is a senior endocrinologist with extensive expertise in the management of neuroendocrine tumors (NETs). He serves as the Head of the Neuroendocrine Tumors Service at the Institute of Endocrinology, Sheba Medical Center.
His clinical and academic focus includes hereditary syndromes associated with neuroendocrine tumor development. Prof. Tirosh is affiliated with the National Institutes of Health (NIH) in the field of MEN1 syndrome. He is also part of an international expert panel on von Hippel–Lindau (VHL) disease and has contributed to clinical guidelines for the management of VHL patients. At Sheba Medical Center, he acts as the primary contact physician within the multidisciplinary VHL clinic.
Research and Academic Activity
Prof. Tirosh leads an active research program focused on bioinformatics in endocrine oncology, with particular emphasis on neuroendocrine tumors. As Head of the Endocrine Oncology Bioinformatics Laboratory, he collaborates with leading research institutions in the United States, Italy, and Germany, as well as with scientists from the Weizmann Institute of Science.
In his role at the Endocrinology and Diabetes Research Center, he provides patients with advanced, state-of-the-art treatment options for NETs. He is also actively involved in teaching and regularly lectures medical students at Tel Aviv University’s Faculty of Medicine.
Clinical Expertise
Endocrinology
Neuroendocrine tumors (NETs)
Peptide Receptor Radionuclide Therapy (PRRT)
Current Position
Head of Neuroendocrine Tumors Service,
The Endocrine Institute & Endocrine Oncology Bioinformatics Lab,
The Endocrinology and Diabetes Research Center
Education and Training
MD, Hadassah Medical School, Hebrew University of Jerusalem
Residency in Internal Medicine, Assaf HaRofeh Medical Center
Fellowship in Endocrinology, Rabin Medical Center
Advanced training in Neuroendocrine Tumors and Endocrine Tumor Genetics, National Institutes of Health (Maryland, USA)
Board Certification
Endocrinology
Professional Memberships
Israeli Society of Endocrinology
American Endocrine Society
European Neuroendocrine Tumors Society
Scientific Publications
Prof. Tirosh is the author of more than 40 peer-reviewed publications in leading medical journals, including JAMA, Oncology, Gastroenterology, Cancer, Journal of Clinical Endocrinology & Metabolism, and Radiology.
Selected articles include:
Postoperative hyperglycemia following insulinoma resection: incidence and management
Nockel P, Tirosh A, et al.
Radiation exposure from CT surveillance in patients with VHL-associated pancreatic tumors
Tirosh A, Journy N, et al.
Radioguided surgery using Gallium-68 DOTATATE in neuroendocrine tumors
El Lakis M, Tirosh A, et al.
Radiotherapist
Oncosurgeon
Dr. Tamar Jablonski-Perec is an oncologist at Hadassah Medical Center in Jerusalem. She holds a Doctor of Medical Sciences from the Hebrew University and has experience from the renowned Sloan-Kettering Cancer Center in New York. She is the Head of Institute of Oncology, Head of Breast Cancer Treatment Center, and Professor of the Department of Oncology at the Hebrew University. She is a member of several international cancer communities and was awarded a scholarship from the Hadassah Medical School.
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 23年の経験 | 膵癌手術 | 王立マースデン病院での研修を経て、消化管腫瘍を専門とする。HIPEC等の高度な手技を提供し、臨床研究の共同プロジェクトを主導している。 | イスラエル | から $825 | |
| #2 | 41年の経験 | 膵臓癌の研究と治療 | 数十年にわたる腫瘍学の専門知識を持つ上級研究者で、膵臓癌を専門とする。ESMOのメンバーであり、腫瘍内科外来の部長。 | イスラエル | から $950 | |
| #3 | 34年の経験 | 膵臓癌進行症例 | イスラエル国家がん政策評議会の議長兼ソウラスキー医療センター腫瘍科部長。国家戦略を主導し、次世代の腫瘍専門医を育成している。 | イスラエル | お問い合わせください |